Marpai is an AI tech company revolutionizing the self-funded health plan
market representing over $1 trillion in health claims, $20 billion in
administrative fees, and 95 million Americans. Just as Netflix, Amazon,
Uber, and Tesla use artificial intelligence to transform and lead industry
sectors, Marpai (pronounced Mar-pay) is using deep learning, the most
advanced artificial intelligence, to transform health plan administration
for companies who self-fund their health plans. As a next-generation
TPA (Third Party Administrator) using SMART technology (deeplearning powered), Marpai’s mission is to save lives, improve lives, and
radically reduce the costs of healthcare for employers and plan
members.
DSS Inc. (NYSE American: DSS) is a multinational company operating business segments in blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets. Its business model is based on a distribution sharing system in which shareholders will receive shares in its subsidiaries as DSS strategically spins them out into IPOs. DSS is led by its seasoned leaders with decades of industry experience.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, tissues, and living cells for their research, with the available biospecimens. Its iSpecimen Marketplace platform solves this problem and transforms the biospecimen procurement process to accelerate medical discovery.
Medigus Ltd is an Israel-based medical device company. It is engaged in the development, manufacturing, and marketing of surgical endostaplers and direct vision systems for minimally invasive medical procedures. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incisionless treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how.
Bragg Gaming Group is a next generation gaming group with cutting-edge technology, leading brands and world-class management expertise, developing into a global gaming force. Formed by a team of gaming industry experts, Bragg's main portfolio asset is ORYX Gaming, an innovative business-to-business gaming technology platform and casino content aggregator. Through this brand and targeted acquisitions, Bragg is focused on becoming a leader within the evolving global gaming industry.
DeFi Technologies builds and manages assets in the rapidly emerging decentralized financial market, providing institutional and retail investors easy access to previously unseen returns through innovative projects and groundbreaking protocols that are fundamentally reshaping the global financial system.
Medalist Diversified REIT (NASDAQ: MDRR) was founded in 2003 as a private equity company specializing in acquiring, owning, and managing commercial real estate in the Southeast. The Company’s strategy is to focus on value-add and opportunistic commercial real estate which is expected to provide an attractive balance of risk and returns. Medalist utilizes a rigorous, consistent, and replicable process for sourcing and conducting due diligence of acquisitions. The Company seeks to maximize operating performance of current properties by utilizing a hands-on approach to property management while monitoring the middle market real estate markets in the Southeast for acquisition opportunities and disposal of properties as considered appropriate.
Draganfly has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. From public safety to pop culture, Draganfly has shaped not just the UAV industry, but the way people around the world work and live. Breaking ground with international firsts, Draganfly has a legacy of leading the professional drone industry, including releasing the first commercialized quadrotor UAV in 1999 and releasing the first multirotor UAV with an integrated camera system in 2001. In 2013, Draganflyer was credited as the world’s first small unmanned aerial system (sUAS) to save a person’s life, and in 2016, Draganfly became the first company to have multiple UAV systems deemed Transport Canada Compliant.
DSS Inc. (NYSE American: DSS) is a multinational company operating business segments in blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets. Its business model is based on a distribution sharing system in which shareholders will receive shares in its subsidiaries as DSS strategically spins them out into IPOs. DSS is led by its seasoned leaders with decades of industry experience.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, tissues, and living cells for their research, with the available biospecimens. Its iSpecimen Marketplace platform solves this problem and transforms the biospecimen procurement process to accelerate medical discovery.
Medigus Ltd is an Israel-based medical device company. It is engaged in the development, manufacturing, and marketing of surgical endostaplers and direct vision systems for minimally invasive medical procedures. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incisionless treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how.
Bragg Gaming Group is a next generation gaming group with cutting-edge technology, leading brands and world-class management expertise, developing into a global gaming force. Formed by a team of gaming industry experts, Bragg's main portfolio asset is ORYX Gaming, an innovative business-to-business gaming technology platform and casino content aggregator. Through this brand and targeted acquisitions, Bragg is focused on becoming a leader within the evolving global gaming industry.
DeFi Technologies builds and manages assets in the rapidly emerging decentralized financial market, providing institutional and retail investors easy access to previously unseen returns through innovative projects and groundbreaking protocols that are fundamentally reshaping the global financial system.
Medalist Diversified REIT (NASDAQ: MDRR) was founded in 2003 as a private equity company specializing in acquiring, owning, and managing commercial real estate in the Southeast. The Company’s strategy is to focus on value-add and opportunistic commercial real estate which is expected to provide an attractive balance of risk and returns. Medalist utilizes a rigorous, consistent, and replicable process for sourcing and conducting due diligence of acquisitions. The Company seeks to maximize operating performance of current properties by utilizing a hands-on approach to property management while monitoring the middle market real estate markets in the Southeast for acquisition opportunities and disposal of properties as considered appropriate.
Draganfly has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. From public safety to pop culture, Draganfly has shaped not just the UAV industry, but the way people around the world work and live. Breaking ground with international firsts, Draganfly has a legacy of leading the professional drone industry, including releasing the first commercialized quadrotor UAV in 1999 and releasing the first multirotor UAV with an integrated camera system in 2001. In 2013, Draganflyer was credited as the world’s first small unmanned aerial system (sUAS) to save a person’s life, and in 2016, Draganfly became the first company to have multiple UAV systems deemed Transport Canada Compliant.
1847 Holdings LLC (1847) seeks to provide non-correlated returns by combining the most attractive attributes of owning private, lower-middle market businesses with the liquidity and transparency of a publicly traded company. 1847’s unique structure permits flow-through tax treatment for shareholders. As a result, 1847 will seek to generate returns for shareholders through consistent, annual distributions of operating subsidiary income and capital appreciation resulting from the timely sale of operating subsidiaries. 1847’s current portfolio includes Neese Inc., an agricultural industry services company with a 27-year operating history and growing market share in waste disposal services, and Goedeker’s, one of the top-30 largest appliance retailers in the country.
Draganfly has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. From public safety to pop culture, Draganfly has shaped not just the UAV industry, but the way people around the world work and live. Breaking ground with international firsts, Draganfly has a legacy of leading the professional drone industry, including releasing the first commercialized quadrotor UAV in 1999 and releasing the first multirotor UAV with an integrated camera system in 2001. In 2013, Draganflyer was credited as the world’s first small unmanned aerial system (sUAS) to save a person’s life, and in 2016, Draganfly became the first company to have multiple UAV systems deemed Transport Canada Compliant.
Mercer Capital's Value Focus: Medtech & Device Industry | Q4 2018 Mercer Capital
Mercer Capital provides valuation services to start ups, larger public and private companies, and private equity and venture capital funds. Mercer Capital’s expertise in the medtech and device industry spans the following segments: Biotechnology and life sciences, medical devices, and healthcare technology.
Draganfly has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. From public safety to pop culture, Draganfly has shaped not just the UAV industry, but the way people around the world work and live. Breaking ground with international firsts, Draganfly has a legacy of leading the professional drone industry, including releasing the first commercialized quadrotor UAV in 1999 and releasing the first multirotor UAV with an integrated camera system in 2001. In 2013, Draganflyer was credited as the world’s first small unmanned aerial system (sUAS) to save a person’s life, and in 2016, Draganfly became the first company to have multiple UAV systems deemed Transport Canada Compliant.
Draganfly has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. From public safety to pop culture, Draganfly has shaped not just the UAV industry, but the way people around the world work and live. Breaking ground with international firsts, Draganfly has a legacy of leading the professional drone industry, including releasing the first commercialized quadrotor UAV in 1999 and releasing the first multirotor UAV with an integrated camera system in 2001. In 2013, Draganflyer was credited as the world’s first small unmanned aerial system (sUAS) to save a person’s life, and in 2016, Draganfly became the first company to have multiple UAV systems deemed Transport Canada Compliant.
Insurers are continuing to face marked changes in what customers expect in terms of products and service, how they obtain and utilize the information that informs business decisions, and their underlying business and operating models. Top Insurance Industry Issues in 2016 describes in detail the internal and external changes insurers face and how they can gain a competitive advantage..
Newt is a cloud-based Software as a Service (SaaS) platform enabling enterprises to offer digital financial products and services. Digital financial technologies and infrastructure are reshaping payments, commerce, and access to financial services, creating a growing market opportunity for digital financial service disruptors like Newt.
Document Security Systems (DSS) is a multinational company operating businesses focused
on brand protection technology, blockchain security, direct marketing, healthcare, real estate,
and securitized digital assets. Its business model is based on a distribution sharing system in
which shareholders will receive shares in its subsidiaries as DSS strategically spins them out
into IPOs. Its historic business revolves around counterfeit deterrent and authentication
technologies, smart packaging, and consumer product engagement. DSS is led by its seasoned
leaders with decades of industry experience.
Newt is a cloud-based Software as a Service (SaaS) platform enabling enterprises to offer digital financial products and services. Digital financial technologies and infrastructure are reshaping payments, commerce, and access to financial services, creating a growing market opportunity for digital financial service disruptors like Newt.
In spring 2016, PwC investigated the current state and
future direction of stress testing. We surveyed 55 insurers
operating in the US about their stress testing framework and
the specific stresses that they test. We also engaged in more
detailed dialogue with a number of insurers in the US and
globally, as well as with some North American insurance
regulators.
American International Holdings (AMIH) is an investor, developer and asset manager of diversified, synergistic health and wellness businesses. Today, the AMIH portfolio encompasses telemedicine and other virtual health platforms, affordable subscriber-based primary care and concierge medicine plans, preventative care solutions and wellness related assets such as mental & behavioral health services, as well as its own proprietary life coaching platform. AMIH markets its various services through direct-to-consumer and business-to-business distribution channels. AMIH’s focus is on bringing to market technologies and solutions that advance the quality of life for the global community.
Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs, develops and commercializes innovative diagnostic and therapeutic injection technologies and instruments for medical and dental applications. Milestone's computer-controlled systems are designed to make injections precise, efficient, virtually painless, and less expensive. Milestone’s proprietary DPS® Dynamic Pressure Sensing technology® platform advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for epidural space identification in regional anesthesia procedures.
Insurers are upgrading their technology to support more complex
products, lower operating costs, and get closer to their customers.
But they can do more harm than good when they make changes
that alienate their independent agents. We’ve identified five steps
that can help insurers engage agents early and create a
transition plan that meets agents’ needs—converting these
important stakeholders into enthusiastic advocates.
Pwc 2015 Technology Sector Sec Comment Letter TrendsPwC
PwC's technology industry publication provides a comprehensive analysis of recent SEC staff comments and disclosures to assist you in understanding the key trends relevant to companies in the technology sector.
Marpai is an AI tech company revolutionizing the self-funded health plan
market representing over $1 trillion in health claims, $20 billion in
administrative fees, and 95 million Americans. Just as Netflix, Amazon,
Uber, and Tesla use artificial intelligence to transform and lead industry
sectors, Marpai (pronounced Mar-pay) is using deep learning, the most
advanced artificial intelligence, to transform health plan administration
for companies who self-fund their health plans. As a next-generation
TPA (Third Party Administrator) using SMART technology (deeplearning powered), Marpai’s mission is to save lives, improve lives, and
radically reduce the costs of healthcare for employers and plan
members.
1847 Holdings LLC (1847) seeks to provide non-correlated returns by combining the most attractive attributes of owning private, lower-middle market businesses with the liquidity and transparency of a publicly traded company. 1847’s unique structure permits flow-through tax treatment for shareholders. As a result, 1847 will seek to generate returns for shareholders through consistent, annual distributions of operating subsidiary income and capital appreciation resulting from the timely sale of operating subsidiaries. 1847’s current portfolio includes Neese Inc., an agricultural industry services company with a 27-year operating history and growing market share in waste disposal services, and Goedeker’s, one of the top-30 largest appliance retailers in the country.
Draganfly has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. From public safety to pop culture, Draganfly has shaped not just the UAV industry, but the way people around the world work and live. Breaking ground with international firsts, Draganfly has a legacy of leading the professional drone industry, including releasing the first commercialized quadrotor UAV in 1999 and releasing the first multirotor UAV with an integrated camera system in 2001. In 2013, Draganflyer was credited as the world’s first small unmanned aerial system (sUAS) to save a person’s life, and in 2016, Draganfly became the first company to have multiple UAV systems deemed Transport Canada Compliant.
Mercer Capital's Value Focus: Medtech & Device Industry | Q4 2018 Mercer Capital
Mercer Capital provides valuation services to start ups, larger public and private companies, and private equity and venture capital funds. Mercer Capital’s expertise in the medtech and device industry spans the following segments: Biotechnology and life sciences, medical devices, and healthcare technology.
Draganfly has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. From public safety to pop culture, Draganfly has shaped not just the UAV industry, but the way people around the world work and live. Breaking ground with international firsts, Draganfly has a legacy of leading the professional drone industry, including releasing the first commercialized quadrotor UAV in 1999 and releasing the first multirotor UAV with an integrated camera system in 2001. In 2013, Draganflyer was credited as the world’s first small unmanned aerial system (sUAS) to save a person’s life, and in 2016, Draganfly became the first company to have multiple UAV systems deemed Transport Canada Compliant.
Draganfly has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. From public safety to pop culture, Draganfly has shaped not just the UAV industry, but the way people around the world work and live. Breaking ground with international firsts, Draganfly has a legacy of leading the professional drone industry, including releasing the first commercialized quadrotor UAV in 1999 and releasing the first multirotor UAV with an integrated camera system in 2001. In 2013, Draganflyer was credited as the world’s first small unmanned aerial system (sUAS) to save a person’s life, and in 2016, Draganfly became the first company to have multiple UAV systems deemed Transport Canada Compliant.
Insurers are continuing to face marked changes in what customers expect in terms of products and service, how they obtain and utilize the information that informs business decisions, and their underlying business and operating models. Top Insurance Industry Issues in 2016 describes in detail the internal and external changes insurers face and how they can gain a competitive advantage..
Newt is a cloud-based Software as a Service (SaaS) platform enabling enterprises to offer digital financial products and services. Digital financial technologies and infrastructure are reshaping payments, commerce, and access to financial services, creating a growing market opportunity for digital financial service disruptors like Newt.
Document Security Systems (DSS) is a multinational company operating businesses focused
on brand protection technology, blockchain security, direct marketing, healthcare, real estate,
and securitized digital assets. Its business model is based on a distribution sharing system in
which shareholders will receive shares in its subsidiaries as DSS strategically spins them out
into IPOs. Its historic business revolves around counterfeit deterrent and authentication
technologies, smart packaging, and consumer product engagement. DSS is led by its seasoned
leaders with decades of industry experience.
Newt is a cloud-based Software as a Service (SaaS) platform enabling enterprises to offer digital financial products and services. Digital financial technologies and infrastructure are reshaping payments, commerce, and access to financial services, creating a growing market opportunity for digital financial service disruptors like Newt.
In spring 2016, PwC investigated the current state and
future direction of stress testing. We surveyed 55 insurers
operating in the US about their stress testing framework and
the specific stresses that they test. We also engaged in more
detailed dialogue with a number of insurers in the US and
globally, as well as with some North American insurance
regulators.
American International Holdings (AMIH) is an investor, developer and asset manager of diversified, synergistic health and wellness businesses. Today, the AMIH portfolio encompasses telemedicine and other virtual health platforms, affordable subscriber-based primary care and concierge medicine plans, preventative care solutions and wellness related assets such as mental & behavioral health services, as well as its own proprietary life coaching platform. AMIH markets its various services through direct-to-consumer and business-to-business distribution channels. AMIH’s focus is on bringing to market technologies and solutions that advance the quality of life for the global community.
Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs, develops and commercializes innovative diagnostic and therapeutic injection technologies and instruments for medical and dental applications. Milestone's computer-controlled systems are designed to make injections precise, efficient, virtually painless, and less expensive. Milestone’s proprietary DPS® Dynamic Pressure Sensing technology® platform advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for epidural space identification in regional anesthesia procedures.
Insurers are upgrading their technology to support more complex
products, lower operating costs, and get closer to their customers.
But they can do more harm than good when they make changes
that alienate their independent agents. We’ve identified five steps
that can help insurers engage agents early and create a
transition plan that meets agents’ needs—converting these
important stakeholders into enthusiastic advocates.
Pwc 2015 Technology Sector Sec Comment Letter TrendsPwC
PwC's technology industry publication provides a comprehensive analysis of recent SEC staff comments and disclosures to assist you in understanding the key trends relevant to companies in the technology sector.
Marpai is an AI tech company revolutionizing the self-funded health plan
market representing over $1 trillion in health claims, $20 billion in
administrative fees, and 95 million Americans. Just as Netflix, Amazon,
Uber, and Tesla use artificial intelligence to transform and lead industry
sectors, Marpai (pronounced Mar-pay) is using deep learning, the most
advanced artificial intelligence, to transform health plan administration
for companies who self-fund their health plans. As a next-generation
TPA (Third Party Administrator) using SMART technology (deeplearning powered), Marpai’s mission is to save lives, improve lives, and
radically reduce the costs of healthcare for employers and plan
members.
Based in Ann Arbor, Michigan, Zomedica is a veterinary health company creating diagnostic and therapeutic products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. With modest cash burn and a strong balance sheet, including $142.4 million cash and cash equivalents as of June 30, 2023, Zomedica is well-positioned to fund both organic growth and acquisitions.
Dócola is a social good organization with the only free care communication platform that consolidates thousands of free and low-cost patient education resources from the leading nonprofit, government, and commercial organizations in one marketplace. Plus, you can easily create and upload your own resources.
INNO HOLDINGS INC. is an innovative building-technology company with a mission to transform the construction industry with our proprietary cold-formed steel- framing technology and other building innovations
Everything Blockchain builds platforms of trust for the modern enterprise and is on a mission to ensure every organization has access to the tools and platforms that enable them to manage, store, and protect data without the cost and complexity that holds them back today. The Company’s patented advances in engineering deliver the essential elements needed for real-world business use: speed, security, and efficiency. Everything Blockchain’s current business lines include: EB Advise, Build DB and EB Control.
ASP Isotope is an isotope enrichment company utilizing technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses. Many of these elements are unsuitable for enrichment using traditional methods such as centrifuges. The Company’s initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries.
MDNA Life Sciences is a pioneer in the science of mitochondrial DNA. It’s our mission to create an extensive portfolio of proprietary tests that dramatically improve diagnosis, treatment, prognosis and monitoring. Putting an end to the unnecessary surgical procedures, pain and uncertainty that affect patients across the world.
Digital Ally, Inc. is a diversified holding company with operations in video solution technology, human and animal health protection products, healthcare revenue cycle management, ticket brokering and marketing, and event production. The Company pursues an acquisition strategy that targets organizations with positive earnings, strong growth potential, innovation, and operational synergies. To maximize long-term shareholder value, Digital Ally intends to spin-off its ticketing and entertainment business lines into a separate public company in 2023. The spin-off will create two optimized, tech-driven public companies with strong growth opportunities and operating metrics.
Lantern Pharma is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Our proprietary AI and machine learning (ML) platform, RADR®, leverages over 25 billion oncology-focused data points and a library of 200+ advanced ML algorithms to help solve billion-dollar, real-world problems in oncology drug development. By harnessing the power of AI and with input from world-class scientific advisors and collaborators, we have accelerated the development of our growing pipeline of therapies including eleven cancer indications and an antibody-drug conjugate (ADC) program. On average, our newly developed drug programs have been advanced from initial AI insights to first-in-human clinical trials in 2-3 years and at approximately $1.0-2.0 million per program.
Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. The Company’s product lines focus on low waste and ultra-low waste syringe technologies that incorporate both passive and active safety features. These features protect front line healthcare workers from life-threatening needle stick injuries and protect the public from needle re-use. Sharps Technology has extensive expertise in specialized prefilled syringe systems and is on track to launch this new product line in Q4 2023. The Company has a manufacturing facility in Hungary and has partnered with Nephron Pharmaceuticals to expand its manufacturing capacity in the US.
Aditxt is a global innovation company focused on discovering and developing precision medicine innovations and deploying them into high-performing businesses. Aditxt’s diverse innovation portfolio includes: Adimune™, Inc., developing and designing a new class of therapeutics for retraining the immune system to address organ rejection, autoimmunity, and allergies; Adivir™, Inc., focused on identifying, developing and commercializing new ways to treat infectious diseases; and Pearsanta™, Inc., offering convenient, rapid, personalized, and high-quality lab testing —anytime and anywhere at its CLIA certified and CAP accredited clinical laboratory based in Richmond, VA.
1847 Holdings LLC, a publicly traded diversified acquisition holding company, was founded by Ellery W. Roberts, a former partner of Parallel Investment Partners, Saunders Karp & Megrue and Principal of Lazard Freres Strategic Realty Investors. EFSH's investment thesis is that capital market inefficiencies have left the founders and/or stakeholders of many small business enterprises and lower-middle market businesses with limited exit options, despite the intrinsic value of their business. Given this dynamic, EFSH can consistently acquire "solid" businesses for reasonable multiples of cash flow and then deploy resources to strengthen the infrastructure and systems to improve operations. These improvements may lead to a sale or IPO of an operating subsidiary at considerably higher valuations than the purchase price (as successfully demonstrated with the mid-2020 IPO of 1847 Goedeker on the NYSE American) and/or alternatively, an operating subsidiary may be held in perpetuity and contribute to EFSH's ability to pay regular and special dividends to shareholders.
Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. The Company’s product lines focus on low waste and ultra-low waste syringe technologies that incorporate both passive and active safety features. These features protect front line healthcare workers from life-threatening needle stick injuries and protect the public from needle re-use. Sharps Technology has extensive expertise in specialized prefilled syringe systems and is on track to launch this new product line in Q4 2023. The Company has a manufacturing facility in Hungary and has partnered with Nephron Pharmaceuticals to expand its manufacturing capacity in the US.
SPI Energy is a global renewable energy company and provider of solar storage and electric vehicle (EV) solutions that was founded in 2006 in Roseville, California and is headquartered in McClellan Park, California. The Company has three core divisions: SolarJuice which has solar wholesale distribution, as well as residential solar and roofing installation and solar module manufacturing (Solar4America & SEM Wafertech), SPI Solar and Orange Power which operates a commercial & utility solar division, and the EdisonFuture/Phoenix Motor EV division. SolarJuice is the leader in renewable energy system solutions for residential and small commercial markets and has extensive operations in the Asia Pacific and North America markets. The SPI Solar commercial & utility solar division provides a full spectrum of EPC services to third party project developers, and develops, owns and operates solar projects that sell electricity to the grid in multiple regions, including the U.S., U.K., and Europe. Phoenix Motor is a leader in medium-duty commercial electric vehicles, and is developing EV charger solutions, electric pickup trucks, electric forklifts, and other EV products. SPI maintains global operations in North America, Australia, Asia and Europe and is also targeting strategic investment opportunities in fast growing green energy industries such as battery storage, charging stations, and other EVs which leverage the Company's expertise and substantial solar cash flow.
BullFrog AI is a technology enabled drug development company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University and J. Craig Venter Institute, BullFrog AI is at the forefront of AI-driven drug development. Using its proprietary bfLEAP™ artificial intelligence platform, BullFrog AI aims to enable the successful development of pharmaceuticals and biologics by predicting which patients will respond to therapies in development. BullFrog AI is deploying bfLEAP™ for use at several critical stages of development with the intention of streamlining data analytics in therapeutics development, decreasing the overall development costs by decreasing failure rates for new therapeutics, and impacting the lives of countless patients that may have otherwise not received the therapies they need.
BullFrog AI is a technology enabled drug development company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University and J. Craig Venter Institute, BullFrog AI is at the forefront of AI-driven drug development. Using its proprietary bfLEAP™ artificial intelligence platform, BullFrog AI aims to enable the successful development of pharmaceuticals and biologics by predicting which patients will respond to therapies in development. BullFrog AI is deploying bfLEAP™ for use at several critical stages of development with the intention of streamlining data analytics in therapeutics development, decreasing the overall development costs by decreasing failure rates for new therapeutics, and impacting the lives of countless patients that may have otherwise not received the therapies they need.
BioVie is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. The Company is developing NE3107 for Alzheimer’s (AD) and Parkinson’s (PD) and BIV201 for refractory ascites and HRS-AKI.
Lantern Pharma is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Our proprietary AI and machine learning (ML) platform, RADR®, leverages over 25 billion oncology-focused data points and a library of 200+ advanced ML algorithms to help solve billion-dollar, real-world problems in oncology drug development. By harnessing the power of AI and with input from world-class scientific advisors and collaborators, we have accelerated the development of our growing pipeline of therapies including eleven cancer indications and an antibody-drug conjugate (ADC) program. On average, our newly developed drug programs have been advanced from initial AI insights to first-in-human clinical trials in 2-3 years and at approximately $1.0-2.0 million per program.
Genetic Technologies is a diversified molecular diagnostics company. A global leader in genomics-based tests in health, wellness and serious disease through its geneType and EasyDNA brands. GENE offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a proprietary risk stratification platform that has been developed over the past decade and integrates clinical and genetic risk to deliver actionable outcomes to physicians and individuals. Leading the world in risk prediction in oncology, cardiovascular and metabolic diseases, Genetic Technologies continues to develop risk assessment products.
Splash Beverage Group, an innovator in the beverage industry, owns a growing portfolio of alcoholic and non-alcoholic beverage brands including Copa di Vino wines by the glass, SALT naturally flavored tequilas, Pulpoloco Sangria, and TapouT performance hydration and recovery drinks and TapouT Cognitive Energy Drink. Splash’s strategy is to rapidly develop early-stage brands already in its portfolio as well as acquire and then accelerate brands that have high visibility or are innovators in their categories. Led by a management team that has built and managed some of the top brands in the beverage industry and led sales from product launch into the billions, Splash is rapidly expanding its brand portfolio and global distribution.
Splash Beverage Group, an innovator in the beverage industry, owns a growing portfolio of alcoholic and non-alcoholic beverage brands including Copa di Vino wines by the glass, SALT naturally flavored tequilas, Pulpoloco Sangria, and TapouT performance hydration and recovery drinks and TapouT Cognitive Energy Drink. Splash’s strategy is to rapidly develop early-stage brands already in its portfolio as well as acquire and then accelerate brands that have high visibility or are innovators in their categories. Led by a management team that has built and managed some of the top brands in the beverage industry and led sales from product launch into the billions, Splash is rapidly expanding its brand portfolio and global distribution.
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...Jeffrey Haguewood
Sidekick Solutions uses Bonterra Impact Management (fka Social Solutions Apricot) and automation solutions to integrate data for business workflows.
We believe integration and automation are essential to user experience and the promise of efficient work through technology. Automation is the critical ingredient to realizing that full vision. We develop integration products and services for Bonterra Case Management software to support the deployment of automations for a variety of use cases.
This video focuses on the notifications, alerts, and approval requests using Slack for Bonterra Impact Management. The solutions covered in this webinar can also be deployed for Microsoft Teams.
Interested in deploying notification automations for Bonterra Impact Management? Contact us at sales@sidekicksolutionsllc.com to discuss next steps.
Securing your Kubernetes cluster_ a step-by-step guide to success !KatiaHIMEUR1
Today, after several years of existence, an extremely active community and an ultra-dynamic ecosystem, Kubernetes has established itself as the de facto standard in container orchestration. Thanks to a wide range of managed services, it has never been so easy to set up a ready-to-use Kubernetes cluster.
However, this ease of use means that the subject of security in Kubernetes is often left for later, or even neglected. This exposes companies to significant risks.
In this talk, I'll show you step-by-step how to secure your Kubernetes cluster for greater peace of mind and reliability.
Essentials of Automations: Optimizing FME Workflows with ParametersSafe Software
Are you looking to streamline your workflows and boost your projects’ efficiency? Do you find yourself searching for ways to add flexibility and control over your FME workflows? If so, you’re in the right place.
Join us for an insightful dive into the world of FME parameters, a critical element in optimizing workflow efficiency. This webinar marks the beginning of our three-part “Essentials of Automation” series. This first webinar is designed to equip you with the knowledge and skills to utilize parameters effectively: enhancing the flexibility, maintainability, and user control of your FME projects.
Here’s what you’ll gain:
- Essentials of FME Parameters: Understand the pivotal role of parameters, including Reader/Writer, Transformer, User, and FME Flow categories. Discover how they are the key to unlocking automation and optimization within your workflows.
- Practical Applications in FME Form: Delve into key user parameter types including choice, connections, and file URLs. Allow users to control how a workflow runs, making your workflows more reusable. Learn to import values and deliver the best user experience for your workflows while enhancing accuracy.
- Optimization Strategies in FME Flow: Explore the creation and strategic deployment of parameters in FME Flow, including the use of deployment and geometry parameters, to maximize workflow efficiency.
- Pro Tips for Success: Gain insights on parameterizing connections and leveraging new features like Conditional Visibility for clarity and simplicity.
We’ll wrap up with a glimpse into future webinars, followed by a Q&A session to address your specific questions surrounding this topic.
Don’t miss this opportunity to elevate your FME expertise and drive your projects to new heights of efficiency.
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...UiPathCommunity
💥 Speed, accuracy, and scaling – discover the superpowers of GenAI in action with UiPath Document Understanding and Communications Mining™:
See how to accelerate model training and optimize model performance with active learning
Learn about the latest enhancements to out-of-the-box document processing – with little to no training required
Get an exclusive demo of the new family of UiPath LLMs – GenAI models specialized for processing different types of documents and messages
This is a hands-on session specifically designed for automation developers and AI enthusiasts seeking to enhance their knowledge in leveraging the latest intelligent document processing capabilities offered by UiPath.
Speakers:
👨🏫 Andras Palfi, Senior Product Manager, UiPath
👩🏫 Lenka Dulovicova, Product Program Manager, UiPath
DevOps and Testing slides at DASA ConnectKari Kakkonen
My and Rik Marselis slides at 30.5.2024 DASA Connect conference. We discuss about what is testing, then what is agile testing and finally what is Testing in DevOps. Finally we had lovely workshop with the participants trying to find out different ways to think about quality and testing in different parts of the DevOps infinity loop.
Transcript: Selling digital books in 2024: Insights from industry leaders - T...BookNet Canada
The publishing industry has been selling digital audiobooks and ebooks for over a decade and has found its groove. What’s changed? What has stayed the same? Where do we go from here? Join a group of leading sales peers from across the industry for a conversation about the lessons learned since the popularization of digital books, best practices, digital book supply chain management, and more.
Link to video recording: https://bnctechforum.ca/sessions/selling-digital-books-in-2024-insights-from-industry-leaders/
Presented by BookNet Canada on May 28, 2024, with support from the Department of Canadian Heritage.
Builder.ai Founder Sachin Dev Duggal's Strategic Approach to Create an Innova...Ramesh Iyer
In today's fast-changing business world, Companies that adapt and embrace new ideas often need help to keep up with the competition. However, fostering a culture of innovation takes much work. It takes vision, leadership and willingness to take risks in the right proportion. Sachin Dev Duggal, co-founder of Builder.ai, has perfected the art of this balance, creating a company culture where creativity and growth are nurtured at each stage.
Generating a custom Ruby SDK for your web service or Rails API using Smithyg2nightmarescribd
Have you ever wanted a Ruby client API to communicate with your web service? Smithy is a protocol-agnostic language for defining services and SDKs. Smithy Ruby is an implementation of Smithy that generates a Ruby SDK using a Smithy model. In this talk, we will explore Smithy and Smithy Ruby to learn how to generate custom feature-rich SDKs that can communicate with any web service, such as a Rails JSON API.
Elevating Tactical DDD Patterns Through Object CalisthenicsDorra BARTAGUIZ
After immersing yourself in the blue book and its red counterpart, attending DDD-focused conferences, and applying tactical patterns, you're left with a crucial question: How do I ensure my design is effective? Tactical patterns within Domain-Driven Design (DDD) serve as guiding principles for creating clear and manageable domain models. However, achieving success with these patterns requires additional guidance. Interestingly, we've observed that a set of constraints initially designed for training purposes remarkably aligns with effective pattern implementation, offering a more ‘mechanical’ approach. Let's explore together how Object Calisthenics can elevate the design of your tactical DDD patterns, offering concrete help for those venturing into DDD for the first time!
State of ICS and IoT Cyber Threat Landscape Report 2024 previewPrayukth K V
The IoT and OT threat landscape report has been prepared by the Threat Research Team at Sectrio using data from Sectrio, cyber threat intelligence farming facilities spread across over 85 cities around the world. In addition, Sectrio also runs AI-based advanced threat and payload engagement facilities that serve as sinks to attract and engage sophisticated threat actors, and newer malware including new variants and latent threats that are at an earlier stage of development.
The latest edition of the OT/ICS and IoT security Threat Landscape Report 2024 also covers:
State of global ICS asset and network exposure
Sectoral targets and attacks as well as the cost of ransom
Global APT activity, AI usage, actor and tactic profiles, and implications
Rise in volumes of AI-powered cyberattacks
Major cyber events in 2024
Malware and malicious payload trends
Cyberattack types and targets
Vulnerability exploit attempts on CVEs
Attacks on counties – USA
Expansion of bot farms – how, where, and why
In-depth analysis of the cyber threat landscape across North America, South America, Europe, APAC, and the Middle East
Why are attacks on smart factories rising?
Cyber risk predictions
Axis of attacks – Europe
Systemic attacks in the Middle East
Download the full report from here:
https://sectrio.com/resources/ot-threat-landscape-reports/sectrio-releases-ot-ics-and-iot-security-threat-landscape-report-2024/
Connector Corner: Automate dynamic content and events by pushing a buttonDianaGray10
Here is something new! In our next Connector Corner webinar, we will demonstrate how you can use a single workflow to:
Create a campaign using Mailchimp with merge tags/fields
Send an interactive Slack channel message (using buttons)
Have the message received by managers and peers along with a test email for review
But there’s more:
In a second workflow supporting the same use case, you’ll see:
Your campaign sent to target colleagues for approval
If the “Approve” button is clicked, a Jira/Zendesk ticket is created for the marketing design team
But—if the “Reject” button is pushed, colleagues will be alerted via Slack message
Join us to learn more about this new, human-in-the-loop capability, brought to you by Integration Service connectors.
And...
Speakers:
Akshay Agnihotri, Product Manager
Charlie Greenberg, Host
Neuro-symbolic is not enough, we need neuro-*semantic*Frank van Harmelen
Neuro-symbolic (NeSy) AI is on the rise. However, simply machine learning on just any symbolic structure is not sufficient to really harvest the gains of NeSy. These will only be gained when the symbolic structures have an actual semantics. I give an operational definition of semantics as “predictable inference”.
All of this illustrated with link prediction over knowledge graphs, but the argument is general.
2. | 2
Forward Looking Statements
The Company filed a registration statement on Form S-1, as amended (Registration No.: 333-258029) (the “Registration Statement”) with the Securities and Exchange Commission for
its initial public offering of shares of class A common stock which was declared effective on October 26, 2021. The Company consummated its initial public offering on October 29,
2021. You should read the Registration Statement and other documents that we have filed with the Securities and Exchange Commission for more complete information about us and
the offering. You may get these documents for free by visiting EDGAR on the Commission’s website at www.sec.gov.
All statements in this presentation, other than those relating to historical facts, are "forward‐looking statements.” These forward‐looking statements may include, but are not limited to,
statements relating to our objectives, plans, and strategies; statements that contain projections of results of operations or of financial condition; statements relating to the research,
development, and use of our platform technologies, technologies, models and modules, products and product offerings; and all statements (other than statements of historical facts)
that address activities, events, or developments that we intend, expect, project, believe, or anticipate will or may occur in the future. Forward‐looking statements are not guarantees of
future performance and are subject to risks and uncertainties. We have based these forward‐looking statements on assumptions and assessments made by our management in light
of their experience and their perception of historical trends, current conditions, expected future developments, and other factors they believe to be appropriate. Important factors that
could cause actual results, developments, and business decisions to differ materially from those anticipated in these forward‐looking statements include, among other things: the
overall global economic environment; the impact of competition and new technologies; general market, political, and economic conditions in the jurisdictions in which we operate;
projected capital expenditures and liquidity; changes in our strategy; government regulations and approvals; and litigation and regulatory proceedings.
We caution you that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and the
development of the industry in which we operate may differ materially from the forward-looking statements contained in this presentation as a result of, among other factors, the factors
referenced in the “Risk Factors” section of the Registration Statement. In addition, even if our results of operations, financial condition and liquidity, and the development of the industry
in which we operate are consistent with the forward-looking statements contained in this presentation, they may not be predictive of results or developments in future periods.
This presentation shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any of our securities. Any offering of securities can only be
made in compliance with applicable securities laws. You should read carefully the factors described in the “Risk Factors” section of the Registration Statement to better understand the
risks and uncertainties inherent in our business and underlying any forward-looking statements. These statements are only current predictions and are subject to known and unknown
risks, uncertainties, and other factors that may cause our or our industry’s actual results, levels of activity, performance, or achievements to be materially different from those
anticipated by the forward‐looking statements. You should not rely upon forward‐looking statements as predictions of future events. Although we believe that the expectations reflected
in the forward‐looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Except as required by law, we are under no
duty to update or revise any of the forward‐looking statements, whether as a result of new information, future events or otherwise, after the date of this presentation. These
forward‐looking statements speak only as of the date of this presentation, and we assume no obligation to update or revise these forward‐looking statements for any reason.
This presentation is not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident or located in any locality, state, country or other jurisdiction
where such distribution, transmission, publication, availability or use would be contrary to law or regulation or which would require any registration or licensing within such jurisdiction.
4. Transforming a $1+ Trillion Segment of
Healthcare Industry with Deep Learning
| 4
Creating Healthier Lives
Radically Reducing Healthcare Costs
Quality Care
Preventative Care
Fear & Complexity
Transforming Self-Insured Health Plans
PREDICTIVE
PROACTIVE
EFFICIENT
AI
Deep
Learning
Goals:
Sources: McLellan Consulting Services for $1+ trillion segment of the healthcare industry
5. Market
Our Market:
Self-Funded Employers Paying $20+ Billion in
Third Party Administration Fees1
| 5
Fully Insured
Health Plan
Pay insurance company to
handle it all
OR
GROWING
133k businesses with 50+ employees3
39M employee lives4
Pay health costs directly
• Use TPA to process & manage
• Use Stop Loss to mitigate risk
Self Funded
Health Plan
Employer
Sponsored
Health Plans
49% of Americans
receive employer
sponsored health insurance
157M people2
Employers
Sources:
1 Company analysis based on estimated $44 PEPM x 39M employee lives (McLellan Consulting Services)
2 Kaiser Family Foundation 2020 report
3 Kaiser Family Foundation 2020 report, NAICS
4 McLellan Consulting Services
6. Solid Foundation to Scale
| 6
Strong
Pipeline for
2021 and
beyond
Short list of
M&A targets
(buying books
of business)
Covering
40K+
Lives
44 States
20k employee lives
Serving
60
Clients
15 using AI
and Growing
Who We Are
World-Class
Networks
including
LTM 6/30/21
Revenue: $16.2M
Unit Economics:
$63 PEPM
2020 VOLUMES: 534k+ Claims Processed $620M Filed Claims $202M Total Paid
TOTAL SAVINGS: $418M
7. Tech Brings Revolutionizing Alternative
| 7
TPA’s
Pay Less $$
More Risk
Low Tech, Cumbersome
Self Insured
OLD WORLD PAYERS: ESTABLISHED
BUCA’s
Pay A Lot $$$
No Transparency
No Control
Fully Insured
TECH–FIRST PAYERS
Lower Costs
Simple, Responsive, Personalized
High Automation
NEW WORLD PAYERS: TECH-FIRST
Taking business from traditional BUCA’s & TPA’s
Deep Learning Difference
9. Machine Learning vs.
Deep Learning
Raw Data Vector of features
Deep Learning
Machine Learning
Raw Data
Greatest leap in accuracy in the history of AI, due to deep learning.
Deep Learning
Barriers of Entry
Increasing
Complexity
Scarcity
of Experts
Challenging
to Deploy
Deep Learning Difference
| 9
10. | 10
Predict
High Cost
Surgeries and
Imaging
Predict
Chronic
Conditions
Personalized
Health
Recommendations
FUTURE
Potential
Marpai AI
Applications
Present & Future
Data Sources
Medical Claims
Rx Claims
SDOH
Member Preferences
Provider Quality
Ratings
Network Data
Wearable Devices
IoT Devices
EHR
Images
Lab Results
Provider Schedules
Deep Learning Difference
+ +
11. Investment Opportunity
| 11
High Margin
Tech-driven cost reduction
High Revenue Growth
Superior product offering
Organic +
Acquisitions
Highly Differentiated
Predict, Prevent and Protect
Who We Are
PROPRIETARY ALGORITHMS TECH PLATFORM INNOVATIVE BRAND LOYAL CUSTOMERS
MOAT
Goal:
reduce
cost to 1/3
of
industry
Higher
AI-enable
d quality
care
12. Our Products
| 12
Differentiated Products
Proactive
Engagement
Create Healthier Member Behavior
Nudges, reminds, inspires, anticipates, empowers
TopCare
Match Members with Top Providers
Recommends top 10% of providers
FutureSight
Advantage
Predict, Prevent, Protect
Early Detection + Intervention = Best Care
Proprietary
Algorithms
SMART Plan
Administration
Manage and Pay Claims Efficiently
Automation of Processes + Elimination of Errors
13. SMART Plan Administration
Making Marpai an efficient TPA
| 13
Key Features
• Creates efficiencies
• Eliminates abuse, cost excesses, errors
• Accelerates workflows
• Provides 24/7 responsive service
• Collects data to yield new insights
Blueprint for Acquisitions
• Automated 2/3 of system queues
• Reduced staff of acquired company by 1/3
• AI eliminated claims errors pre-acceptance
• AI simplified e-data transfer
• Met 100% of Aetna + Cigna performance metrics
Differentiated Products
14. FutureSight Advantage
• Diabetes Type 2
• Cardiovascular
Disease
• Kidney Disease
• COPD
• Knee Surgery
• Knee Replacement
• Knee imaging
Now
Chronic conditions
•Hypertension
•Hyperlipidemia
•IHD
•Heart Failure
•Asthma
Major Procedures
•Abdomen and Pelvic CT
•Knee Arthroscopy
•Spinal Canal MRI
Coming Soon
Predicts, Prevents, Protects
Chronic and mental
health conditions are
90% of annual U.S.
healthcare costs
| 14
MARPAI PROPRIETARY ALGORITHMS
50Total - Highest Cost Areas
Differentiated Products
Source: CDC’s National Center for Chronic Disease Prevention and Health Promotion
15. Case Study
Total Savings
$118,739
ROI 397%
Recommends
Top 10%
of Providers
Drives Members to
High Quality/Lower Cost Care
Additional Stop Loss
Discount
5%-10%
| 15
220 Employees, 55 referrals
Marpai TopCare
Differentiated Products
16. | 16
Variation in Cost of Common Procedures
We believe that AI-enabled prediction allows us to guide members to the best care in terms of cost and
quality
Source: company analysis, actual client data
Cost Savings
17. | 17
MEMBER
PORTAL
To empower members to do the
right things at the right times with
the most qualified providers
Friendly nudges,
alerts, reminders,
content, incentives
Proactive
Engagement
Differentiated Products
18. Expansion of Unit Economics
| 18
We plan for the expansion of per employee per month fee (PEPM) to be potentially driven by AI and
related new services
6/30/2021 PEPM
$63
Financials
Drivers of PEPM Growth
• Adoption of TopCare by current client base
• New AI-driven products
• Increased revenue share via preferred vendor
program (e.g. care management and telehealth)
• Potential revenue from clients’ cost savings
• Higher medical plan administration fees
19. Drivers of Growth
| 19
Organic Drivers
• Better products, powered by AI
• Significant expansion in sales and marketing
• Innovative marketing campaigns and events
• Tech adoption and growth from existing customers
Acquisition Drivers
• Analyzed 200 potential targets for roll-up strategy
• Targets typically sell at 1x LTM revenue
• Top 10 targets total $432M revenue and 581k lives:
We believe that Marpai’s deep learning platform has the potential to serve as the foundation for the company to
become a disruptive consolidator in the self-funded health plan space
Financials
New Win:
Texas School Districts, +20% employee lives
Source: company estimates of targets’ revenues and lives
22. Seasoned
Leadership Team
Edmundo
Gonzalez
CEO
Ronnie Brown
COO
Alice Roth
President of
Marpai Labs
Eli David
Chief Science Advisor
Art Hoath
CRO
Yoram Bibring
CFO
Yaron Eitan
Chairman
Who We Are
| 22
Board of
Directors
Edmundo
Gonzalez
CEO
Damien
Lamendola
Gonen Antebi
Independent
Director Nominee
Jane Cavalier
Independent
Director Nominee
Yaron Eitan
Chairman
Colleen DiClaudio
Independent Director
Nominee
Vincent Kane
Independent
Director Nominee
23. Investment Summary
$20+ Billion Market Opportunity
| 23
Tech-Driven Strategy with Advanced AI
Highly differentiated AI products
Growth Model is Working
+20% New Lives Implemented 9/1
Predict Health States
Prevent Illness
& Big Claims
+
Organic + Acquisitions
High
Margin
Claims
Costs
Highly Efficient Payer